• Type 2 Diabetes Medications and Glaucoma Risk

  • Jan 30 2025
  • Length: 18 mins
  • Podcast

Type 2 Diabetes Medications and Glaucoma Risk

Listen for free

View show details

  • Summary

  • How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, “Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.”

    Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes. Muayad, Jawad et al. Ophthalmology. In press.
    Show more Show less
Show more Show less

What listeners say about Type 2 Diabetes Medications and Glaucoma Risk

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available